Explore the vast range of titles available.

National arts reporter Geoff Edgers interviewed musician Yo-Yo Ma on Instagram live on April 16.

Background and objectives The adverse impacts of climate change on mental health is a burgeoning area, although findings are inconsistent. The emerging concept of eco-anxiety represents distress in relation to climate change and may be related to mental health. The aim of this study was to explore the relationship between eco-anxiety with validated mental health outcomes, specifically psychological distress and symptoms of major affective disorders. Design Systematic review. Methods EBSCO, ProQuest, and Web of Science databases were searched to February 2024 for studies of adult samples quantifying eco-anxiety (exposure, i.e. fear, worry or anxiety in relation to climate change) and symptoms of psychological distress and major affective disorders (outcomes), as assessed by validated measures. Results Full text review of 83 studies was performed, and k  = 35 studies were included in the review ( N  = 45 667, 61% female, M age 31.2 years). Consistently, eco-anxiety showed small to large positive correlations with mental health outcomes of psychological distress, depression symptoms, anxiety symptoms, and stress symptoms. However, results regarding post-traumatic stress disorder symptoms and pathological worry were mixed. Stronger associations were observed where eco-anxiety was operationalised as ‘anxiety’ rather than ‘worry’. Conclusions Findings underscore that eco-anxiety is related to psychological burden. Greater consideration of eco-anxiety in assessment and treatment is needed in clinical practice and further policy development is warranted at the intersection of climate and health to address the mental health challenges posed by climate change.

Abstract Introduction It is intuitive to expect youth with IBD will have higher rates of depression and anxiety than their otherwise healthy peers, and most research bears this notion. However, existing literature of emotional distress has not consistently addressed the differentiation between general depression and anxiety and normative emotional experiences of IBD. Assessment measures often used for youth with IBD align with the DSM criteria; based on symptoms, without considering etiology or context (e.g., chronic disease). The IBD Distress Scale (IDS) was designed to identify distress/worry in response to extraordinary circumstances of having IBD. Methods The IDS is a 27-item measure of distress related to IBD symptoms, treatment, and disease burden. The youth self-report was completed by 108 patients ages 12–19, and 101 parents. The IDS measure was administered with general measures of depression (Patient Health Questionnaire, PHQ8) and anxiety (General Anxiety Disorder, GAD7) to youth with IBD attending their routine gastroenterology appointment. Item responses were classified as “not a problem,” “moderate problem,” or “serious problem.” For some analyses, “not a problem” and “moderate problem” were collapsed. Correlations and frequencies were conducted to compare youth and parent responses. Results Results identified top “serious problems” rated by youth and parents, separately. The highest rated problem for youth was worries about not being able to eat what others are eating, with 18% reporting this as a serious problem. The second most highly rated “serious problem” by youth was fear of not having bathroom access (15%). For parents, the highest rated “serious problem” was fear of surgery (24%). Parents also rated worrying about next flare, and feeling there’s no way to avoid a flare, as “serious problems,” both with 16% frequency. Pearson correlations for the top problems identified as “serious” by youth and parents revealed significant agreement for socially-oriented worries; e.g., anxiety about patient not being able to eat what others are eating (r=.33). Conclusion The CCF states IBD treatment goals are five-fold: achieve remission; control inflammation; maintain remission; prevent and manage complications; maximize quality of life. Based on research with other diseases, integrating the IDS into current IBD treatment protocols is a logical step for identifying target areas for treatment. Thematically, results revealed youth and parents worry about future-oriented (e.g., worrying about next flare) and socially-oriented issues (e.g., possibility of not having access to a bathroom). The identified themes enlighten current treatment and provide guidance for improved interventions. Future directions should include development and implementation of appropriate interventions specific to the identified serious problems for IBD distress.

Evidence suggests cannabidiol (CBD) displays broad therapeutic potential in the context of anxiety; however, no study has examined the effects of CBD on worry, a defining, cognitive feature of anxiety. Additionally, no study has examined the effects of an acute, single dose of CBD compared to repeated CBD administration. Within a sample of 63 individuals with elevated trait worry, the current study aimed to assess the effects of an empirically-derived high dose of CBD (i.e., 300mg) compared to a commercially-derived dose of CBD (i.e., 50mg) versus placebo on worry severity and anxiety symptoms after an acute dose and after a 2-week administration period. Taken together, these findings suggest 300mg of oral CBD does not attenuate cognitive symptoms of anxiety (i.e., worry), following both acute and repeated administration. Some evidence for repeated administration of 300mg on physical symptoms of anxiety was obtained. Findings from the current study suggest CBD's modest anxiolytic effects may be specific to the physical aspects of anxious arousal.

Evidence suggests cannabidiol (CBD) displays broad therapeutic potential in the context of anxiety; however, no study has examined the effects of CBD on worry, a defining, cognitive feature of anxiety. Additionally, no study has examined the effects of an acute, single dose of CBD compared to repeated CBD administration. Within a sample of 63 individuals with elevated trait worry, the current study aimed to assess the effects of an empirically-derived high dose of CBD (i.e., 300mg) compared to a commercially-derived dose of CBD (i.e., 50mg) versus placebo on worry severity and anxiety symptoms after an acute dose and after a 2-week administration period. Taken together, these findings suggest 300mg of oral CBD does not attenuate cognitive symptoms of anxiety (i.e., worry), following both acute and repeated administration. Some evidence for repeated administration of 300mg on physical symptoms of anxiety was obtained. Findings from the current study suggest CBD's modest anxiolytic effects may be specific to the physical aspects of anxious arousal.

Concern over the rapidly evolving metaverse is growing, leading to the development of the \"metaverse worry\". Therefore, the purpose of this study is to develop an appropriate psychometric instrument to measure metaverse worry. The Metaverse Worry Inventory (MWI) was developed through two studies (N = 672). In Study 1, rigorous processes including item analysis, exploratory factor analysis and confirmatory factor analysis revealed two reliable factors for the 10-item inventory: negative belief and negative feeling. The MWI had excellent internal consistency (Cronbach’s α = 0.89) and medium test-retest reliability ( r = 0.62). In study 2, good criterion-related validity of the MWI was confirmed by examining the MWI's relationship with intolerance of uncertainty and Big Five personality. The MWI captured the latent variables of metaverse worry and is essential for promoting metaverse development and alleviating worries.

“Dementia worry” (DW; i.e., concern about developing dementia) is highly prevalent in the general population. However, research on the characteristics associated with lower and higher levels of DW is still limited. Based on previous empirical and conceptual work, we examined the extent to which DW was related to a comprehensive range of objective and subjective characteristics (sociodemographics, contact with people with dementia, physical health-related risk factors, well-being/psychological distress, aging self-perceptions, social-cognitive health beliefs about dementia). A convenience sample of N  = 219 German adults 40 + years ( M  = 65.50 years, SD = 11.34; 40–94 years) reporting no dementia or cognitive impairment diagnosis completed questionnaires. We improved upon previous research by using a ten-item scale to measure DW. We used bivariate correlations and multivariate regression to examine the extent to which DW was related to the potential concomitants. 41.1% of the participants indicated DW. Together, the predictor variables explained 53.3% of the variance in DW. DW was related to psychological distress, perceived memory change, aging anxiety, and personal risk perception in both the bivariate and multivariate analyses. There was a quadratic (reverse U shape) relationship between age and DW. Physical health-related risk factors were not related to DW. Our findings suggest that DW represents a hybrid of psychological distress, aging self-perceptions, and a specific type of health concern. Healthcare practitioners should consider a person’s psychological characteristics when deciding how to intervene when someone indicates moderate or high DW.